To determine whether repeated FDG-PET-CT-scans can predict increased disease-specific survival after induction chemotherapy followed by radical cystectomy.
Between 2007 and 2018, 86 patients with clinically node-positive bladder cancer (T1-T4, N1-N3, M0-M1a) were included and underwent a repeated FDG-PET-CT during cisplatin-based induction chemotherapy.